IMRX · Immuneering Corporation
AI read · Good for IMRX
The AI's read
These results give Immuneering more support for testing atebimetinib with other cancer drugs. The strongest result described came from an animal model, so it cannot show whether patients will benefit. The ongoing study must answer that.